Usewithnonsteroidalanti-inflammatorydrugs,aspirin,antiplateletagglutinants,dextran,andantivitaminKbecauseofthepotentialrisks.
1.Generaltreatment:120U/kgeachtime,2timesaday.2.PreventionofpostoperativeDVTformation:(1)diheparinsodium2500Uwasgiven1~2hoursbeforesurgery,andthedosewasthesameonceadayfor5~10days.(2)enoxaparinsodium30
Thrombocytopenia,abnormalliverfunctionandinjectionsitebleedingandecchymosisareseen.Occasionallyseetransaminaseandalkalinephosphatasechange.Ithasbeenreportedthatintrathecalepiduralanesthesiaandpostoper
1.(1)patientswithliverandrenalinsufficiency;(2)uncontrolledseverehypertension;(3)patientswithahistoryofpepticulcer.2.Effectsofdrugsonpregnancy:dextroheparinsodiumshouldnotbeusedinthefirst3monthsofpreg